← All companies

LSTA

Lisata Therapeutics, Inc.

LSTA Nasdaq Pharmaceutical Preparations EDGAR ↗

$1.04

+0.01 +0.97%

Key statistics

from XBRL data in SEC filings

Market cap

$9.47M

Revenue (TTM)

$170K

Net income (TTM)

-$16.4M

EPS (TTM)

$-1.86

P/E ratio

—

Dividend yield

—

Free cash flow

-$16.0M

Cash

$13.1M

Total assets

$14.1M

Gross margin

1012.5%

52-week range

$0.99 – $5.07

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Exit or disposal costs; Director or officer change; Other events Aug 4, 2026 8-K Terminated a material agreement; Other events Jul 24, 2026 8-K Entered a material agreement Jul 17, 2026 8-K Entered a material agreement Jun 9, 2026 8-K Other events Jun 1, 2026 8-K Entered a material agreement May 29, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Entered a material agreement May 4, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 28, 2026 8-K Other events Apr 15, 2026 8-K Other events Apr 3, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Entered a material agreement; Regulation FD disclosure Mar 9, 2026 8-K Entered a material agreement Feb 27, 2026 8-K Other events Jan 27, 2026 8-K Entered a material agreement; Other events Jan 21, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 6, 2025 8-K Regulation FD disclosure Oct 14, 2025 8-K Entered a material agreement Oct 8, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 7, 2025 8-K Other events Jul 15, 2025 8-K Regulation FD disclosure Jun 26, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jun 17, 2025 8-K Director or officer change Jun 13, 2025 8-K Shareholder vote results Jun 10, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 8, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 27, 2025 8-K Regulation FD disclosure Jan 23, 2025 8-K Entered a material agreement Dec 3, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 12, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 12, 2024 8-K Results of operations (earnings release) Jun 27, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 9, 2024